metaEvidence - overview


			DCR
mGC or mGEJC - L2 - all population metastatic/advanced mGC or mGEJC mGC or mGEJC - 2nd Line (L2) mGC or mGEJC - L2 - all population
versus paclitaxel
	avelumab alone vs. paclitaxel	1
	pembrolizumab alone vs. paclitaxel	1	-
versus placebo
	nivolumab alone vs. placebo	1
versus Standard of Care (SoC)
	Ipilimumab (10 mg/kg) vs. Standard of Care (SoC)	1	-
mGC or mGEJC - L2 - PDL1 positive metastatic/advanced mGC or mGEJC mGC or mGEJC - 2nd Line (L2) mGC or mGEJC - L2 - PDL1 positive
versus paclitaxel
	pembrolizumab alone vs. paclitaxel	1	-